- Biden Will Move to Have Medicare, Medicaid Cover GLP-1 Weight-Loss Meds
- Cold Plunge or Hot Bath? What’s Best for Ailing Muscles?
- Concussions Slow Brain Activity in High School Football Players
- Study Finds GLP-1 Meds Can Also Help the Kidneys
- Long COVID Brain Fog: Could the Lungs Hold Clues?
- Scientists Spot Gene That Could Help Cause Miscarriages
- Preschoolers’ Tantrums Can Be Early Sign of ADHD
- Mom’s Healthy Diet in Pregnancy Pays Big Dividends for Baby
- There’s a Best Option for Patients With Head-and-Neck Cancer Who Can’t Take Cisplatin
- Program Tripled Number of Completed At-Home Colon Cancer Tests
AI Outperforms Eye Docs in Managing Glaucoma
FRIDAY, Feb. 23, 2024 (HealthDay news) — Artificial intelligence can match and even outperform human eye doctors in diagnosing and treating glaucoma, a new study finds.
The GPT-4 system from OpenAI did as well or better than ophthalmologists in assessing 20 different patients for glaucoma and retinal disease, researchers report Feb. 22 in the journal JAMA Ophthalmology.
“AI was particularly surprising in its proficiency in handling both glaucoma and retina patient cases, matching the accuracy and completeness of diagnoses and treatment suggestions made by human doctors in a clinical note format,” said senior study author Dr. Louis Pasquale, deputy chair for ophthalmology research at the New York Eye and Ear Infirmary of Mount Sinai.
The results suggest that AI could play an important support role for ophthalmologists as they try to manage patients’ glaucoma.
“Just as the AI application Grammarly can teach us how to be better writers, GPT-4 can give us valuable guidance on how to be better clinicians, especially in terms of how we document findings of patient exams,” Pasquale said in an infirmary news release.
Glaucoma is notoriously difficult to diagnose. About half of the 3 million Americans with glaucoma don’t know they have it, according to the American Academy of Ophthalmology (AAO).
Glaucoma occurs when fluid pressure builds up inside the eye, damaging the optic nerve and creating blind spots in a person’s vision, the AAO says.
For this study, researchers used a basic set of 20 questions about glaucoma and retina disease to test the AI program against a set of 12 attending ophthalmologists and three senior trainees.
Responses were then statistically analyzed and rated for accuracy and thoroughness.
AI outperformed eye doctors in response to glaucoma diagnosis and management, results show. For retinal disease, AI matched humans in accuracy, but exceeded them in completeness.
Advanced AI tools like GPT-4 are trained on vast amounts of data, text and images, researchers noted.
Lead researcher Dr. Andy Huang, an ophthalmology resident at the New York Eye and Ear Infirmary of Mount Sinai, said the results show AI can help treat eye diseases.
“It could serve as a reliable assistant to eye specialists by providing diagnostic support and potentially easing their workload, especially in complex cases or areas of high patient volume,” Huang said.
“For patients, the integration of AI into mainstream ophthalmic practice could result in quicker access to expert advice, coupled with more informed decision-making to guide their treatment,” Huang added.
More information
The American Academy of Ophthalmology has more about glaucoma.
SOURCE: New York Eye and Ear Infirmary of Mount Sinai, news release, Feb. 22, 2024
Source: HealthDay
Copyright © 2024 HealthDay. All rights reserved.